These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
310 related items for PubMed ID: 18080981
1. [The variability of peak inspiratory flow (PIF) on valves imitating dry powder inhalers resistance during asthma and COPD exacerbations]. Grabowski M, Barg W, Chmielowicz B, Kopeć A, Panaszek B. Pneumonol Alergol Pol; 2007; 75(4):324-30. PubMed ID: 18080981 [Abstract] [Full Text] [Related]
2. [Measurement of inspiratory flow for the selection of the inhalation treatment device for asthma and COPD]. Plavec D, Gluncić TJ, Gudelj I, Mise K. Lijec Vjesn; 2012; 134(3-4):84-9. PubMed ID: 22768682 [Abstract] [Full Text] [Related]
3. Inhalation profiles in asthmatics and COPD patients: reproducibility and effect of instruction. Broeders ME, Molema J, Hop WC, Folgering HT. J Aerosol Med; 2003; 16(2):131-41. PubMed ID: 12823907 [Abstract] [Full Text] [Related]
4. Inspiratory flow rates at different levels of resistance in elderly COPD patients. Janssens W, VandenBrande P, Hardeman E, De Langhe E, Philps T, Troosters T, Decramer M. Eur Respir J; 2008 Jan; 31(1):78-83. PubMed ID: 17898020 [Abstract] [Full Text] [Related]
5. [Ambulatory criteria of dry powder inhaler selection based on peak inspiratory flow recordings]. Droszcz W, Droscez P. Pneumonol Alergol Pol; 2002 Jan; 70(9-10):490-5. PubMed ID: 12710102 [Abstract] [Full Text] [Related]
7. Measurement of inspiratory flow in children with acute asthma. Bentur L, Mansour Y, Hamzani Y, Beck R, Elias N, Amirav I. Pediatr Pulmonol; 2004 Oct; 38(4):304-7. PubMed ID: 15334507 [Abstract] [Full Text] [Related]
11. The inhalation characteristics of patients when they use different dry powder inhalers. Azouz W, Chetcuti P, Hosker HS, Saralaya D, Stephenson J, Chrystyn H. J Aerosol Med Pulm Drug Deliv; 2015 Feb; 28(1):35-42. PubMed ID: 24815999 [Abstract] [Full Text] [Related]
12. Novolizer: how does it fit into inhalation therapy? Magnussen H. Curr Med Res Opin; 2005 Feb; 21 Suppl 4():S39-46; discussion S47. PubMed ID: 16138944 [Abstract] [Full Text] [Related]
13. Suboptimal Peak Inspiratory Flow in Patients Hospitalized for COPD Exacerbation: Prevalence and Predictive Factors. González-Montaos A, Pazos-Area L, Represas-Represas C, Ramos-Hernández C, Lojo-Rodríguez I, Priegue-Carrera A, Aballe-Santos L, Fernández-Villar A. J Aerosol Med Pulm Drug Deliv; 2024 Oct; 37(5):225-231. PubMed ID: 39388689 [Abstract] [Full Text] [Related]
14. Age-dependent deterioration of peak inspiratory flow with two kinds of dry powder corticosteroid inhalers (Diskus and Turbuhaler) and relationships with asthma control. Baba K, Tanaka H, Nishimura M, Yokoe N, Takahashi D, Yagi T, Yamaguchi E, Maeda Y, Muto T, Hasegawa T. J Aerosol Med Pulm Drug Deliv; 2011 Dec; 24(6):293-301. PubMed ID: 22047450 [Abstract] [Full Text] [Related]
16. Changes in Peak Inspiratory Flow After Acute Bronchodilation: An Observational Study of Patients with Stable Chronic Obstructive Pulmonary Disease. Pleasants RA, Shaikh A, Henderson AG, Bayer V, Drummond MB. J Aerosol Med Pulm Drug Deliv; 2024 Aug; 37(4):171-179. PubMed ID: 38814000 [Abstract] [Full Text] [Related]
17. Lung characteristics in elderly males and females patients with COPD: differences and optimal use of dry powder inhalers (DPIs). Terzano C, Oriolo F. Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2708-2716. PubMed ID: 28678314 [Abstract] [Full Text] [Related]